Lallemand Health Solutions will showcase its latest science-backed probiotic and postbiotic innovations at SupplySide Global, taking place from 28 to 30 October in Las Vegas. Visitors to Booth #5545 will discover clinically documented solutions supporting some of today’s fastest-growing supplement categories, including sports performance, women’s health, cognitive wellness and healthy ageing.
This year’s presence will also feature the presentation of Probium®, a recent portfolio of ready-to-market probiotic and multi-ingredient formulations developed to help supplement brands bring products to market faster while leveraging the scientific expertise and quality standards of a global probiotic leader.
Healthy ageing and mobility: spotlight on Cerenity™
Among the innovations featured at the booth is Cerenity™, a proprietary probiotic blend developed to support the emerging gut-muscle axis category. “Healthy ageing is evolving beyond lifespan to focus on quality of life, mobility and vitality,” says Isabelle Champié, Vice President of Sales and Marketing. “Cerenity™ represents an exciting innovation designed to support physical function and well-being in ageing and increasingly sedentary populations.”
Recent clinical research evaluating Cerenity™ in combination with a prebiotic demonstrated benefits on physical performance and quality-of-life parameters, further expanding opportunities for brands targeting healthy ageing consumers.
Clinically documented solutions across key life stages
Lallemand Health Solutions will also highlight its growing portfolio of women’s health solutions, including:
- Prenatis™, evaluated in a clinical study involving 180 pregnant women and supporting maternal health and early microbiome development
- Lacidofil®, supporting microbiota balance around C-section delivery
- L. plantarum Rosella1, supported by six clinical studies involving more than 800 women for vaginal microbiota balance
- B. bifidum Rosell®-71, clinically evaluated for digestive comfort during menstruation
Together, these solutions offer scientifically supported opportunities for brands addressing women’s health needs throughout different stages of life.
New findings in cognitive performance
Lallemand Health Solutions will also present new data from a recent clinical study evaluating Cerebiome® in action video gamers. Preliminary findings² demonstrated measurable improvements in:
- Reaction time
- Processing speed
These results further strengthen the growing body of evidence supporting the gut-brain axis and open new possibilities for brands developing products focused on cognitive performance, focus and mental resilience.
Supporting active lifestyles through the microbiome
The sports nutrition market continues to evolve beyond traditional performance products, creating opportunities for solutions that support immunity, digestion, recovery, stress management and overall well-being. The new Lallemand Health Solutions sports platform highlights clinically documented probiotic and postbiotic solutions designed to support active consumers throughout their wellness journey.
Visitors will discover a curated portfolio featuring solutions for:
- Immune readiness during periods of intense training
- Digestive comfort and gut barrier support
- Stress, mood and sleep quality
- Muscle health and healthy ageing
- Nutrient metabolism and recovery support
Award-winning postbiotic for immune resilience
Among the solutions is Immuse®, a clinically documented postbiotic designed to support immune health during periods of physical stress and intensive training. Recognised with industry awards, Immuse® is supported by a growing body of scientific research and addresses increasing consumer demand for evidence-based wellness solutions.
Last year, Lallemand Health Solutions announced a strategic partnership with Kirin Holdings Company, Limited to expand the global reach of this innovative ingredient and support its development across key health categories. “Immuse® addresses growing demand for reliable, science-backed immune solutions that can support active lifestyles while also offering opportunities in broader categories such as daily wellness and skin health,” says Romane Maillet, Marketing Group Manager, Postbiotics.
Probium® Probiotics: ready-to-market complete range for daily or targeted use
As demand for probiotics continues to grow, many supplement brands are seeking ways to enter the category without the complexity, timelines and investment associated with custom product development. Probium® Probiotics addresses this need with a portfolio of market-ready formulations targeting key consumer health segments and designed specifically for agile supplement brands. Combining clinically documented probiotic strains, market-relevant positioning and streamlined commercialisation, Probium® Probiotics offers a faster and lower-risk path to launch.
“Probium® Probiotics was developed for brands that want to launch smarter and move faster,” says Eric Rayes, Senior Sales Director at Lallemand Health Solutions. “These formulations combine decades of probiotic expertise, scientific credibility and operational simplicity, enabling companies to bring trusted probiotic solutions to market with confidence.”
Turning research into commercial opportunities
With more than 90 years of expertise and a portfolio supported by extensive clinical research, Lallemand Health Solutions continues to invest in scientific innovation that translates into meaningful product opportunities for its partners.
“Our mission is not only to advance microbiome science but also to make that science commercially relevant for our customers,” says Isabelle Champié. “SupplySide Global provides an ideal opportunity to exchange ideas, explore innovation opportunities and discuss how clinically documented biotics can help brands differentiate in a competitive marketplace.”
Visit Booth #5545
Visitors are invited to meet with Lallemand Health Solutions experts to discuss formulation and commercialisation opportunities and experience FizzBiotics™ by Lallemand, an innovative sparkling probiotic concept designed to create engaging consumer experiences.
Whether brands are looking to accelerate product launches, enter new health categories or strengthen existing portfolios, Lallemand Health Solutions offers the scientific, regulatory and manufacturing expertise to support successful innovation.
¹ L. plantarum ROSELLA is L. plantarum P17630 (Proge P17630®), licensed from PROGE FARM®, Italy.
² These results should not be considered definitive, as the manuscript is currently under peer review and may be revised.
